$54.73
0.510.94%
al cierre: -
$54.73
N/A
After hour: 4:00 PM EDT
Comments
Loading...
Orientación y previsiones
BioMarin Pharmaceutical emite una orientación sobre las ganancias por acción y los ingresos futuros, lo que ofrece a los inversores una idea de cuánto espera ganar la empresa en los próximos períodos.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
10/27/2025 | BMRN | BioMarin Pharmaceutical | FY | 2025 | $3.50 | $3.60 | $3.82 | $3.15B | $3.20B | $3.18B | |
08/04/2025 | BMRN | BioMarin Pharmaceutical | FY | 2025 | $4.40 | $4.55 | $3.86 | $3.13B | $3.20B | $3.15B | |
05/16/2025 | BMRN | Biomarin Pharmaceutical | FY | 2025 | $4.20 | $4.40 | $4.31 | $3.10B | $3.20B | $3.14B | |
05/01/2025 | BMRN | Biomarin Pharmaceutical | FY | 2025 | $4.20 | $4.40 | $4.30 | $3.10B | $3.20B | $3.14B | |
02/19/2025 | BMRN | Biomarin Pharmaceutical | FY | 2025 | $4.20 | $4.40 | $4.16 | $3.10B | $3.20B | $3.10B | |
10/29/2024 | BMRN | Biomarin Pharmaceutical | FY | 2024 | $3.25 | $3.35 | $2.07 | $2.79B | $2.83B | $2.80B | |
09/04/2024 | BMRN | Biomarin Pharmaceutical | FY | 2024 | $3.10 | $3.25 | $2.04 | $2.75B | $2.83B | $2.80B | |
09/04/2024 | BMRN | Biomarin Pharmaceutical | FY | 2027 | — | — | — | $4.00B | $4.00B | — | |
08/05/2024 | BMRN | Biomarin Pharmaceutical | FY | 2024 | $3.10 | $3.25 | $2.87 | $2.75B | $2.83B | $2.74B | |
04/24/2024 | BMRN | Biomarin Pharmaceutical | FY | 2024 | $2.75 | $2.95 | $1.65 | $2.70B | $2.80B | $2.77B | |
02/22/2024 | BMRN | Biomarin Pharmaceutical | FY | 2024 | $2.60 | $2.80 | $1.96 | $2.70B | $2.80B | $2.83B | |
11/01/2023 | BMRN | Biomarin Pharmaceutical | FY | 2023 | $1.90 | $2.05 | $1.02 | $2.39B | $2.47B | $2.45B | |
07/31/2023 | BMRN | Biomarin Pharmaceutical | FY | 2023 | $1.85 | $2.10 | $1.02 | $2.38B | $2.50B | $2.46B | |
04/26/2023 | BMRN | Biomarin Pharmaceutical | FY | 2023 | $1.80 | $2.05 | $0.95 | $2.38B | $2.50B | $2.46B | |
02/27/2023 | BMRN | Biomarin Pharmaceutical | FY | 2023 | $1.80 | $2.05 | $1.61 | $2.38B | $2.50B | $2.58B | |
10/26/2022 | BMRN | Biomarin Pharmaceutical | FY | 2022 | — | — | — | $2.06B | $2.16B | $2.12B | |
08/03/2022 | BMRN | Biomarin Pharmaceutical | FY | 2022 | — | — | — | $2.06B | $2.16B | $2.11B | |
04/27/2022 | BMRN | Biomarin Pharmaceutical | FY | 2022 | — | — | — | $2.05B | $2.15B | $2.10B | |
02/23/2022 | BMRN | Biomarin Pharmaceutical | FY | 2022 | — | — | — | $2.05B | $2.15B | $2.14B |
PREGUNTAS FRECUENTES
¿Cuál es la orientación más reciente de BioMarin Pharmaceutical (BMRN)?
La orientación más reciente para BioMarin Pharmaceutical (BMRN) se informó el octubre 27, 2025 para el año completo 2025. La empresa proporcionó una guía de ganancias por acción en el rango de $3.50 a $3.60, en comparación con el EPS estimado de $3.82. Además, BioMarin Pharmaceutical pronosticó ingresos entre $3.15B y $3.20B para el trimestre.
Explora orientación y previsión sobre todos los valores.